Women’s Health at the Center of the 2025–2027 Global Public Affairs Agenda – ISTH
ISTH – International Society on Thrombosis and Haemostasis shared a post on LinkedIn:
“Today, the ISTH unveils its 2025–2027 global public affairs agenda, placing women’s health at the center of global policy and advocacy efforts.
From pregnancy-related thrombosis to postpartum hemorrhage and bleeding disorders that uniquely affect women, the ISTH is aligning scientific expertise with evidence-based policy to strengthen health systems worldwide.
With this upcoming International Womens Day in mind, we reaffirm our commitment to equitable care for women worldwide.
Women around the world continue to face profound health inequities:
- 2 billion women and girls lack social protection
- 63% give birth without maternity benefits
- Women are 50% more likely to be misdiagnosed after a heart attack
The science is ready.
The data is clear.
Now policy must follow.
Learn more about the ISTH’s global public affairs initiatives.”
Other posts about International Society on Thrombosis and Haemostasis .
-
Oct 27, 2026, 11:43Tareq Abadl: Hidden Interferences Behind Unexpected Laboratory Results
-
Oct 27, 2026, 11:42Cece Calhoun: ASH Promotes Clinical Research Training and Mentorship for Emerging Hematologists
-
Oct 27, 2026, 11:41Ifeanyichukwu Ifechidere: The Laboratory Challenges of Measuring Direct Factor Xa Inhibitors
-
Oct 27, 2026, 11:39Gene Therapy Offers New Possibilities for Patients with Thalassaemia in the UAE – Thalassaemia International Federation
-
Oct 27, 2026, 11:35Alan Nurden: rFVIIa Prophylaxis May Reduce Bleeding-Related Healthcare Burden in Glanzmann Thrombasthenia
-
Oct 27, 2026, 10:12Cesar Garrido: WFH Connects with Spanish Thrombosis and Haematology Societies
-
Oct 27, 2026, 10:01Chokri Ben Lamine: CAPS After Autologous SCT – Diagnostic Criteria and Key Mimics
-
Oct 27, 2026, 09:45Jean Terrier: COBRRA Trial – Comparing Bleeding Risks Between DOACs
-
Oct 27, 2026, 08:42Kathleen Freson: SLFN14 at the Crossroads of RNA Regulation, Platelet Biogenesis and Inherited Thrombocytopenia